These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 395841)

  • 21. Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
    Svanholm H; Hørder M
    Scand J Urol Nephrol Suppl; 1988; 107():65-70. PubMed ID: 2453920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunofluorescent localization of an androgen-dependent isoenzyme of prostatic acid phosphatase in rat ventral prostate.
    Terracio L; Rule A; Salvato J; Douglas WH
    Anat Rec; 1985 Oct; 213(2):131-9. PubMed ID: 3907418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tissue polypeptide antigen as a marker for prostatic neoplasms. Preliminary study].
    Ruibal A; Durán P; Ibarz L; Fraile M; Roca I; de Torres Mateos JA
    Arch Esp Urol; 1984; 37(5):399-403. PubMed ID: 6517625
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of cultured, human, malignant, prostatic epithelial cells.
    Stonington OG; Szwec N; Webber M
    Natl Cancer Inst Monogr; 1978 Dec; (49):31-3. PubMed ID: 372822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
    Yoshiki T; Okada K; Oishi K; Yoshida O
    Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
    Théodon P; Rymer JC; Chopin D; Kouyoudjian JC; Abbou CC; Auvert J
    Ann Urol (Paris); 1988; 22(3):199-205. PubMed ID: 2456713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
    Cooper EH; Siddall JK; Newling DW; Robinson MR
    Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
    Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
    Mathieu MC; Caillaud JM
    Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of "prostatic" acid phosphatase in human neutrophils.
    Yam LT; Janckila AJ; Li CY; Lam WK
    Invest Urol; 1981 Jul; 19(1):34-8. PubMed ID: 6941946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of specific antigens in prostatic cancer.
    Moncure CW; Johnston CL; Koontz WW; Smith MJ
    Cancer Chemother Rep; 1975; 59(1):105-10. PubMed ID: 1169105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A solid-phase fluorescent immunoassay for human prostatic acid phosphatase.
    Lee CI; Wang MC; Murphy GP; Chu TM
    Cancer Res; 1978 Sep; 38(9):2871-8. PubMed ID: 354781
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor antigen and acid phosphatase isoenzyme in prostatic cancer.
    Chu TM; Bhargava A; Barnard EA; Ostrowski W; Varkarakis MJ; Merrin C; Murphy GP
    Cancer Chemother Rep; 1975; 59(1):97-103. PubMed ID: 48419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunofluorescence for prostatic acid phosphatase: clinical applications.
    Pontes JE; Rose NR; Ercole C; Pierce JM
    J Urol; 1981 Aug; 126(2):187-9. PubMed ID: 7021879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunology of prostatic carcinoma-an overview.
    Frost P; Rose NR; Choe BK
    Semin Oncol; 1976 Jun; 3(2):107-13. PubMed ID: 935881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical markers for prostatic cancer.
    Nadji M; Morales AR
    Ann N Y Acad Sci; 1983; 420():134-9. PubMed ID: 6586093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical aspects of diagnosis and monitoring of prostate cancer.
    Mahler C
    Horm Res; 1989; 32 Suppl 1():55-7; discussion 58. PubMed ID: 2482245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunoperoxidase localization of prostatic acid phosphatase, prostate-specific antigen and gamma seminoprotein in primary and metastatic prostatic carcinoma].
    Yamaguchi K; Sumiya H; Fuse H; Ito H; Shimazaki J; Matsuzaki O
    Nihon Hinyokika Gakkai Zasshi; 1986 May; 77(5):786-90. PubMed ID: 2427766
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunohistochemistry of prostatic acid phosphatase.
    Nadji M; Morales AR
    Ann N Y Acad Sci; 1982; 390():133-41. PubMed ID: 7046588
    [No Abstract]   [Full Text] [Related]  

  • 40. Carcinoma of the prostate with atypical immunohistological features. Clinical and histologic correlates.
    Feiner HD; Gonzalez R
    Am J Surg Pathol; 1986 Nov; 10(11):765-70. PubMed ID: 2430476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.